ABVC BioPharma, Inc. (ABVC) vs Context Therapeutics Inc. (CNTX)

ABVC BioPharma, Inc. and Context Therapeutics Inc. are both Biotechnology companies. ABVC BioPharma, Inc. and Context Therapeutics Inc. are of similar size ($34.1M and $34.0M). Across the 10 metrics below, ABVC BioPharma, Inc. leads on 6 and Context Therapeutics Inc. on 4.

Valuation

Metric ABVC CNTX Biotechnology median
P/E n/m n/m 7.88
P/S 22.77 n/m 11.47
P/B 2.42 0.87 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.20 0.74
EV/Sales 24.03 n/m 10.73
Earnings yield (29.79%) (137.14%) (28.84%)
Free cash flow yield (9.14%) (102.14%) (23.03%)

Profitability

Metric ABVC CNTX Biotechnology median
Gross margin 99.97% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (65.32%) (76.14%) (57.72%)
Return on assets (39.88%) (68.96%) (49.22%)
Return on invested capital (33.45%) 0.00% 0.00%

Growth

Metric ABVC CNTX Biotechnology median
Revenue growth (TTM) 5,035.43% — 5.64%
EPS growth (last fiscal year) 7.14% 17.39% —
Revenue growth, 5-year CAGR (6.20%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABVC CNTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.07 5.81 4.73
Net debt to EBITDA 0.21 1.66 0.96

Dividend

Metric ABVC CNTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ABVC CNTX Biotechnology median
Market cap 33.96m 34.10m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack